Furosemide Market - Introduction

Furosemide is a medication used to reduce edema (extra fluid in the body) due to diseases/conditions such as kidney disease, heart disease, and liver disease. It is also used for the treatment of high blood pressure. Furosemide is sulfamoylanthranilic acid derivative. It is also known as diuretic and is primarily administered orally or intravenously. The injectable or intravenous form is used when the drug cannot be administered orally, especially in patients with chronic diseases. The medication helps the kidneys eliminate unneeded water and salt from the body through urine. It blocks the absorption of sodium, chloride, and water from the fluid in the kidneys. However, furosemide carries many side effects such as dehydration, low blood pressure, and electrolyte depletion. The medication reduces symptoms such as shortness of breath, and swelling of arms, legs, and abdomen.

Furosemide Market – Competitive Landscape

Key players operating in the global furosemide market are Sanofi, Pfizer Inc., Mylan N.V., Emcure Pharmaceuticals, Sun Pharmaceutical Industries Ltd., SteriMax, and Sandoz Canada Inc.

Mylan N.V.

Mylan N.V. is a pharmaceutical company offering generic and branded medications and serves regions including North America, Europe and Rest of World.  The company operates in 140 countries across the globe. The company offers furosemide tablets indicated in adults and pediatric patients for the treatment of edema associated with cirrhosis of the liver, congestive heart failure and renal disease.

Identify the key factors that will drive your company’s growth, Request a brochure of this report here

Pfizer Inc

Pfizer is a global pharmaceutical company manufacturing includes medicines and vaccines and consumer health care products. The company leading supplier of high-quality, difficult-to-manufacture, injectable pharmaceutical and surgical products. Pfizer Inc. offers furosemide injection, solution indicated as adjunctive therapy in acute pulmonary edema and for for the treatment of edema.


Sanofi is a pharmaceutical company engaged in the development, production, and sale of pharmaceuticals and health care products for diabetes, cardiovascular, central nervous system, thrombosis, internal medicine, vaccines, and oncology. Sanofi offers LASIX, furosemide oral solution.

Furosemide Market - Dynamics

Furosemide is indicated for the treatment of edema associated with congestive heart failure, chronic renal failure & other diseases. Rise in prevalence of chronic diseases, increase in number of generic drug manufacturers for furosemide, and growth in number of surgical procedures are expected to drive the furosemide market during the forecast period. Additionally, increase in number of promising drugs in pipeline is anticipated to boost the market during the forecast period

Increase in prevalence of chronic disease

The prevalence of chronic diseases such as heart failure and renal diseases is increasing across the globe. As per the Centre for Disease Control and Prevention (CDC), in the U.S., nearly 5.7 million adults had heart failure in 2016 and half of people with heart failure die within 5 years of diagnosis. According to Emory Healthcare, in the U.S., 550,000 new cases are diagnosed each year. Diabetes and obesity key contributors to rising number of patients with heart failure

Chronic kidney disease is another major health problem. More than 661,000 Americans have kidney failure. According to National Institute of Diabetes and Digestive and Kidney Diseases, more than 661,000 Americans have kidney failure, out of which 468,000 patients are on dialysis, and 193,000 patient live with a functioning kidney transplant. Nearly 47,000 Americans died from kidney disease in 2013.

Expanding operations in future? To get the perfect launch ask for a custom report here

Product recalls to restrain market growth

Voluntary product recall by pharmaceutical companies, and Food and Drug Administration (FDA) and other regulatory authorities is estimated to restrain the market. For instance, in February 2017, Roxane Laboratories Inc recalled 6493 bottles of Furosemide Tablets USP, 20 mg, available with prescription after a complaint about an unusually thick tablet. In October 2015, the company recalled 16,270 bottles of tablets of diuretic furosemide as per the FDA Enforcement Report. The recall was initiated, as the tablets were manufactured using Active Pharmaceutical Ingredient (API) intended for the oral-suspension version of the drug.

Furosemide market dominated by North America

North America is projected to account for the major share of the market in the near future owing to the increase in number of specialty care services for cardiac and kidney patients, and rise in demand for furosemide in health care institutes. Furthermore, rise in availability of medications for chronic disease/conditions in these pharmacies, ease of accessibility, and growth in chain of retail pharmacies supplying medications for furosemide are other key factors likely to support the growth of the market in North America

Asia Pacific market to grow at rapid pace

The market in Asia Pacific is estimated to expand at a faster pace than that in other regions during the forecast period, led by the increase in awareness about management of pulmonary edema among cardiac patients, rise in prevalence of cardiac diseases, and high demand for drugs in ambulatory surgical centers. Additionally, the increase in number of surgical centers and voluntary organizations conducting workshops & programs, rise in focus on adopting strategies for preventive care are likely to boost the growth of the market in the region.

Furosemide Market – Segmentation

The Furosemide market can be bifurcated on the basis of route of administration, distribution channel, and region

In terms of route of administration, the furosemide market can be divided into:

  • Oral
  • Intravenous
  • Others

In terms of distribution channel, the furosemide market can be fragmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The report on furosemide market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The furosemide market report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The furosemide market report also maps the qualitative impact of various market factors on Furosemide market segments and geographies.

Regional analysis for furosemide market includes:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Furosemide Market

Pre Book